-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Maintains Buy on Jade Biosciences, Raises Price Target to $45

Benzinga·04/27/2026 11:51:21
Listen to the news
HC Wainwright & Co. analyst Arthur He maintains Jade Biosciences (NASDAQ:JBIO) with a Buy and raises the price target from $35 to $45.